NK007 helps in mitigating paclitaxel resistance through p38MAPK activation and HK2 degradation in ovarian cancer-Reference-Cited by-同舟云学术

NK007 helps in mitigating paclitaxel resistance through p38MAPK activation and HK2 degradation in ovarian cancer

Published:2019-02-20 Issue:9 Volume:234 Page:16178-16190
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Li Zhenhua¹^ORCID,Tang Xin¹,Luo Yu²,Chen Bangyu¹,Zhou Congcong¹,Wu Xiuqing¹,Tang Zhenping¹,Qi Xiaojie¹,Cao Guangchao¹,Hao Jianlei¹,Liu Zonghua¹,Wang Qingmin³,Yin Zhinan¹,Yang Hengwen¹

Affiliation:

1. The First Affiliated Hospital, Biomedical Translational Research Institute and School of Pharmacy, Jinan University Guangzhou China

2. Department of Immunology Basic Medical College, Guizhou Medical University Guiyang China

3. State Key Laboratory of Elemento‐Organic Chemistry, Institute of Elemento‐Organic Chemistry, Nankai University Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28278

Reference38 articles.

1. Mapping out p38MAPK

2. Prevention of ovarian cancer: Intraepithelial neoplasia;Brewer M. A.;Clinical Cancer Research,2003

3. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase

4. The Evolution of the MAP Kinase Pathways: Coduplication of Interacting Proteins Leads to New Signaling Cascades

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy;Acta Pharmacologica Sinica;2024-04-15

2. Cryptotanshinone suppresses ovarian cancer via simultaneous inhibition of glycolysis and oxidative phosphorylation;Biomedicine & Pharmacotherapy;2024-01

3. Absent in melanoma 2 attenuates proliferation and migration and promotes apoptosis of human colorectal cancer cells by activating P38MAPK signaling pathway;Oncology Research;2024

4. Therapeutic strategies targeting metabolic characteristics of cancer cells;Critical Reviews in Oncology/Hematology;2023-07

5. Oncogenic alterations of metabolism associated with resistance to chemotherapy;Current Molecular Medicine;2023-06-22